Evaluation of Renal Masses with Contrast-Enhanced Ultrasound
- 627 Downloads
The clinical need for characterising small renal masses (SRMs) is increasing due to their rising incidental detection. This increase is especially seen in younger and older generations and concerns mainly SRMs. Diagnostics is mainly made by contrast-enhanced CT or MRI. However, these imaging methods fail to accurately distinguishing benign from malignant SRMs. Other disadvantages of CT or MRI are high costs, the use of ionizing radiation, nephrotoxicity induced by iodine contrast agents or nephrogenic systemic fibrosis (NSF) induced by gadolinium contrast agents. Contrast-enhanced ultrasound (CEUS) is based on ultrasonography and microbubbles to real-time visualize the renal blood flow without the use of nephrotoxic agents or ionizing radiation. This comprehensive review evaluates the capabilities of CEUS in the diagnostics of benign (angiomyolipomas, cysts, oncocytomas, pseudotumors) and malignant masses (renal cell carcinomas), and focuses on possible future treatment.
KeywordsContrast enhanced ultrasound Ultrasound contrast agent Renal cancer Small renal mass Kidney Ablation therapy
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as:• Of importance
- 8.Menogue SR, O'Brien BA, Brown AL, Cohen RJ. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int 2012.Google Scholar
- 12.• Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20. This article provides a good overview of the figures concerning the distribution of benign and malignant renal masses and the involved treatments. PubMedCrossRefGoogle Scholar
- 13.• Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006;175:2027–31. This article reports the amount of unnecessary surgery peformed in exist SRMs of benign origin after surgery in a large study cohort. PubMedCrossRefGoogle Scholar
- 20.• Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann NM, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33:33–59. This article describes the current guidelines and recommendations for the use of CEUS.PubMedCrossRefGoogle Scholar
- 34.Lu Q, Wang W, Huang B, Li C, Li C. Minimal Fat Renal Angiomyolipoma: the initial study with contrast-enhanced ultrasonography. Ultrasound Med Biol 2012;38:1896–901.Google Scholar
- 45.Zhang C, Li X, Hao H, Yu W, He Z, Zhou L. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 2012.Google Scholar
- 58.Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol. 2004;14 Suppl 8:4–10.Google Scholar
- 60.Barwari K, Wijkstra H, van Delden OM, de la Rosette J, Laguna P. Contrast-enhanced ultrasound for the evaluation of the cryolesion after laparoscopic renal cryoablation: an initial report. J Endourol 2012. doi: 10.1089/end.2012.0400.